Cargando…

Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI

Smoking is known to increase cardiovascular events, but the association and mechanisms between smoking and ventricular arrhythmic events in dilated cardiomyopathy (DCMP) are unknown. The purpose of this study is to investigate the hypothesis that smoking is associated with sudden cardiac death (SCD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Junbeom, Lee, Hye-Jeong, Kim, Sook Kyoung, Yi, Jeong-Eun, Shin, Dong Geum, Lee, Jung Myung, Kim, Yookyung, Kim, Young-Jin, Joung, Boyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199322/ https://www.ncbi.nlm.nih.gov/pubmed/30353108 http://dx.doi.org/10.1038/s41598-018-34145-9

Ejemplares similares

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
por: Yi, Jeong-Eun, et al.
Publicado: (2018)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis
por: Theerasuwipakorn, Nonthikorn, et al.
Publicado: (2023)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy
por: Rubiś, Pawel P., et al.
Publicado: (2021)

RE: Relation of Late Gadolinium Enhancement to Increased Ventricular Wall Stress in Dilated Cardiomyopathy
por: Alter, Peter
Publicado: (2016)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis
por: Feng, Xin-Yi, et al.
Publicado: (2023)

Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction
por: Pi, Seung-Hoon, et al.
Publicado: (2018)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
por: Mirelis, Jesús G., et al.
Publicado: (2022)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
por: Mueller, Karin A. L., et al.
Publicado: (2016)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy
por: Holmström, Miia, et al.
Publicado: (2011)

Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy
por: Latus, Heiner, et al.
Publicado: (2015)

Case series: LMNA‐related dilated cardiomyopathy presents with reginal wall akinesis and transmural late gadolinium enhancement
por: Wang, Shuai, et al.
Publicado: (2020)

A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test
por: Park, Junbeom, et al.
Publicado: (2013)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Machine learning analysis of complex late gadolinium enhancement patterns to improve risk prediction of major arrhythmic events
por: Zaidi, Hassan A., et al.
Publicado: (2023)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

The study about the difference of extra cellular volume calculated with T1mapping in dilated cardiomyopathy with and without late gadolinium enhancement
por: Teraoka, Kunihiko, et al.
Publicado: (2015)

Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies
por: Boban, Marko, et al.
Publicado: (2018)

Non-contrast-enhanced T(1) Mapping of Dilated Cardiomyopathy: Comparison between Native T(1) Values and Late Gadolinium Enhancement
por: Yanagisawa, Fumi, et al.
Publicado: (2018)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Semi-quantitative versus quantitative assessments of late gadolinium enhancement extent for predicting spontaneous ventricular tachyarrhythmia events in patients with hypertrophic cardiomyopathy
por: Park, Young Jun, et al.
Publicado: (2020)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m850k7ouksj3rnsnbvj3h64e0c